Seminars in Liver Disease

LinksSchließen

Referenz

Kristensen SL, Rørth R, Jhund PS. et al.
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.

Lancet Diabetes Endocrinol 2019;
7 (10) 776-785

Bibliographische Angaben herunterladen

Aufrufen in: